Brian Abrahams
Stock Analyst at RBC Capital
(4.75)
# 641
Out of 4,600 analysts
1784
Total ratings
54.1%
Success rate
12.9%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KPTI Karyopharm Therapeutics | Maintained: Buy | $8 | $1.96 | +308.16% | 108 | Jul 31, 2026 | |
| NBIX Neurocrine Biosciences | Rated: Buy | $195 → $198 | $166.06 | +19.23% | 93 | Jul 30, 2026 | |
| REGN Regeneron Pharmaceuticals | Rated: Hold | $696 → $737 | $760.66 | -3.11% | 82 | Jul 30, 2026 | |
| PTCT PTC Therapeutics | Maintained: Hold | $85 | $69.10 | +23.01% | 102 | Jul 30, 2026 | |
| CTNM Contineum Therapeutics | Rated: Buy | $22 → $23 | $15.90 | +44.65% | 14 | Jul 30, 2026 | |
| BIIB Biogen | Reiterated: Buy | $242 → $240 | $208.45 | +15.14% | 200 | Jul 29, 2026 | |
| INCY Incyte | Maintained: Hold | $99 → $109 | $120.60 | -9.62% | 137 | Jul 28, 2026 | |
| GILD Gilead Sciences | Maintained: Hold | $120 | $135.25 | -11.28% | 212 | Jul 23, 2026 | |
| KYMR Kymera Therapeutics | Downgraded: Hold | $106 → $115 | $104.39 | +10.16% | 7 | Jul 13, 2026 | |
| NMRA Neumora Therapeutics | Maintained: Buy | $7 → $5 | $1.60 | +212.50% | 21 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $33 | $24.69 | +33.66% | 10 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $36 | $27.15 | +32.60% | 14 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $14 | $9.02 | +55.21% | 99 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $543 → $570 | $478.71 | +19.07% | 150 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $16.39 | +15.92% | 135 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $30.02 | +33.24% | 3 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $30 | $13.11 | +128.83% | 5 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $97 → $135 | $134.19 | +0.60% | 8 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $57 | $42.32 | +34.69% | 20 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $36 | $9.40 | +282.98% | 31 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.5292 | +88.96% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $29.12 | +37.36% | 9 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $26.45 | +5.86% | 58 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $24 → $23 | $49.94 | -53.94% | 6 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $1.05 | +90.48% | 30 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $16 | $17.93 | -10.76% | 10 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $13 | $8.49 | +53.12% | 26 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $82 | $64.01 | +28.10% | 33 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $7.23 | -17.01% | 8 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $128 | $104.33 | +22.69% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39.00 | $50.94 | -23.44% | 1 | Oct 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $15 | $13.32 | n/a | 54 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $288 | $12.39 | n/a | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $8 | $7.18 | n/a | 7 | May 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $2.54 | n/a | 15 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $188 | $390.02 | n/a | 6 | Oct 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $6.82 | n/a | 1 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $190.40 | n/a | 1 | May 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $25.81 | n/a | 2 | May 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $156.72 | n/a | 1 | Apr 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 | $48.28 | n/a | 1 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47 → $47 | $76.27 | n/a | 2 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.75 | $6.22 | n/a | 1 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $43.68 | n/a | 1 | Mar 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.0001 | n/a | 11 | Feb 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $13.71 | n/a | 3 | Feb 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $85.38 | n/a | 1 | Jan 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $5 | $39.05 | n/a | 2 | Nov 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $24.93 | n/a | 1 | Nov 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $39.71 | n/a | 1 | Nov 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $122 | $104.42 | n/a | 3 | Nov 1, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $60.72 | n/a | 4 | Sep 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $34.43 | n/a | 1 | Aug 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $243.80 | n/a | 4 | Aug 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $65.89 | n/a | 4 | Aug 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.30 | n/a | 5 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,115.68 | n/a | 2 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $254.93 | n/a | 2 | Aug 1, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $128.00 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $25.41 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $2.77 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $153.27 | n/a | 1 | Apr 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $38.70 | n/a | 2 | Feb 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.37 | n/a | 1 | Jun 25, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.66 | n/a | 1 | Sep 2, 2009 |
Karyopharm Therapeutics
Jul 31, 2026
Maintained: Buy
Price Target: $8
Current: $1.96
Upside: +308.16%
Neurocrine Biosciences
Jul 30, 2026
Rated: Buy
Price Target: $195 → $198
Current: $166.06
Upside: +19.23%
Regeneron Pharmaceuticals
Jul 30, 2026
Rated: Hold
Price Target: $696 → $737
Current: $760.66
Upside: -3.11%
PTC Therapeutics
Jul 30, 2026
Maintained: Hold
Price Target: $85
Current: $69.10
Upside: +23.01%
Contineum Therapeutics
Jul 30, 2026
Rated: Buy
Price Target: $22 → $23
Current: $15.90
Upside: +44.65%
Biogen
Jul 29, 2026
Reiterated: Buy
Price Target: $242 → $240
Current: $208.45
Upside: +15.14%
Incyte
Jul 28, 2026
Maintained: Hold
Price Target: $99 → $109
Current: $120.60
Upside: -9.62%
Gilead Sciences
Jul 23, 2026
Maintained: Hold
Price Target: $120
Current: $135.25
Upside: -11.28%
Kymera Therapeutics
Jul 13, 2026
Downgraded: Hold
Price Target: $106 → $115
Current: $104.39
Upside: +10.16%
Neumora Therapeutics
Jul 13, 2026
Maintained: Buy
Price Target: $7 → $5
Current: $1.60
Upside: +212.50%
Jul 9, 2026
Rated: Buy
Price Target: $30 → $33
Current: $24.69
Upside: +33.66%
Jul 7, 2026
Maintained: Buy
Price Target: $29 → $36
Current: $27.15
Upside: +32.60%
Jul 7, 2026
Maintained: Buy
Price Target: $13 → $14
Current: $9.02
Upside: +55.21%
Jul 7, 2026
Maintained: Buy
Price Target: $543 → $570
Current: $478.71
Upside: +19.07%
Jul 7, 2026
Maintained: Hold
Price Target: $19
Current: $16.39
Upside: +15.92%
Jun 30, 2026
Maintained: Buy
Price Target: $40
Current: $30.02
Upside: +33.24%
Jun 29, 2026
Maintained: Buy
Price Target: $50 → $30
Current: $13.11
Upside: +128.83%
Jun 23, 2026
Maintained: Hold
Price Target: $97 → $135
Current: $134.19
Upside: +0.60%
Jun 22, 2026
Maintained: Buy
Price Target: $36 → $57
Current: $42.32
Upside: +34.69%
May 26, 2026
Maintained: Buy
Price Target: $51 → $36
Current: $9.40
Upside: +282.98%
May 15, 2026
Maintained: Hold
Price Target: $1
Current: $0.5292
Upside: +88.96%
May 14, 2026
Maintained: Buy
Price Target: $40
Current: $29.12
Upside: +37.36%
May 13, 2026
Maintained: Hold
Price Target: $28
Current: $26.45
Upside: +5.86%
May 12, 2026
Maintained: Sell
Price Target: $24 → $23
Current: $49.94
Upside: -53.94%
May 11, 2026
Maintained: Hold
Price Target: $2
Current: $1.05
Upside: +90.48%
May 11, 2026
Maintained: Hold
Price Target: $13 → $16
Current: $17.93
Upside: -10.76%
May 8, 2026
Maintained: Hold
Price Target: $12 → $13
Current: $8.49
Upside: +53.12%
May 7, 2026
Maintained: Buy
Price Target: $80 → $82
Current: $64.01
Upside: +28.10%
May 7, 2026
Maintained: Hold
Price Target: $6
Current: $7.23
Upside: -17.01%
Apr 7, 2026
Maintained: Buy
Price Target: $128
Current: $104.33
Upside: +22.69%
Oct 26, 2025
Maintained: Buy
Price Target: $39.00
Current: $50.94
Upside: -23.44%
Oct 2, 2023
Maintained: Hold
Price Target: $25 → $15
Current: $13.32
Upside: n/a
Oct 28, 2022
Maintained: Hold
Price Target: $288
Current: $12.39
Upside: n/a
May 16, 2022
Maintained: Hold
Price Target: $9 → $8
Current: $7.18
Upside: n/a
Aug 16, 2021
Maintained: Hold
Price Target: $4
Current: $2.54
Upside: n/a
Oct 26, 2017
Reiterated: Hold
Price Target: $188
Current: $390.02
Upside: n/a
Sep 15, 2017
Initiated Coverage: Buy
Price Target: $23
Current: $6.82
Upside: n/a
May 17, 2017
Reiterated: Buy
Price Target: $135
Current: $190.40
Upside: n/a
May 8, 2017
Reiterated: Hold
Price Target: $68
Current: $25.81
Upside: n/a
Apr 27, 2017
Reiterated: Buy
Price Target: $80
Current: $156.72
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $32
Current: $48.28
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $47 → $47
Current: $76.27
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $8.75
Current: $6.22
Upside: n/a
Mar 7, 2017
Reiterated: Hold
Price Target: $8
Current: $43.68
Upside: n/a
Feb 16, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.0001
Upside: n/a
Feb 9, 2017
Reiterated: Buy
Price Target: $47
Current: $13.71
Upside: n/a
Jan 5, 2017
Reiterated: Buy
Price Target: $42
Current: $85.38
Upside: n/a
Nov 23, 2016
Reiterated: Hold
Price Target: $4 → $5
Current: $39.05
Upside: n/a
Nov 16, 2016
Reiterated: Buy
Price Target: $39
Current: $24.93
Upside: n/a
Nov 16, 2016
Reiterated: Buy
Price Target: $46
Current: $39.71
Upside: n/a
Nov 1, 2016
Reiterated: Buy
Price Target: $122
Current: $104.42
Upside: n/a
Sep 7, 2016
Reiterated: Buy
Price Target: $120
Current: $60.72
Upside: n/a
Aug 25, 2016
Reiterated: Buy
Price Target: n/a
Current: $34.43
Upside: n/a
Aug 25, 2016
Reiterated: Buy
Price Target: n/a
Current: $243.80
Upside: n/a
Aug 22, 2016
Reiterated: Hold
Price Target: n/a
Current: $65.89
Upside: n/a
Aug 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $8.30
Upside: n/a
Aug 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $1,115.68
Upside: n/a
Aug 1, 2016
Reiterated: Hold
Price Target: n/a
Current: $254.93
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: n/a
Current: $128.00
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $25.41
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $2.77
Upside: n/a
Apr 21, 2016
Reiterated: Buy
Price Target: $61
Current: $153.27
Upside: n/a
Feb 23, 2015
Maintained: Hold
Price Target: n/a
Current: $38.70
Upside: n/a
Jun 25, 2012
Downgraded: Hold
Price Target: n/a
Current: $2.37
Upside: n/a
Sep 2, 2009
Downgraded: Hold
Price Target: n/a
Current: $7.66
Upside: n/a